that's the first target based on early results being positive.
after that it is blue sky.
the market for this type of oral anti cholesterol drug is absolutely gigantic.
and the two main players AstraZeneca and Pfizer will be batting for the drug to combine with their statin in order to be best on market. and increase length of patent.
so. if early results continue be to positive. will quickly be 100m market cap.
and then. 500-1b market cap once there is good reason to think the big boys are looking at it.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.010(4.26%) |
Mkt cap ! $51.67M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 25.0¢ | 23.0¢ | $143.6K | 590.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 60000 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 159081 | 1 |
View Market Depth
| Last trade - 15.59pm 20/06/2025 (20 minute delay) ? |
| NYR (ASX) Chart |